337 / 1631
UK NCRI RAPID Trial
PET3
CT/RT
3-yr
PFS
(%)
3-yr OS
(%)
ABVD
x3
Negative
(74.7%)
No Further Rx
(N=211)
90.8 99.5
IFRT
(N=209)
94.5 97.0
Positive
(25.3%)
ABVDx1 +
IFRT
(N=145)
85.9 93.9
3 year PFS 94.5% (91.3%-97.7) versus 90.8% (86.8-94.7%) HR 1.51 in favour of
IFRT p=0.23
Radford J
et al., NEJM 2015
R